SIRPA and Thrombocytopenia: To assess the safety of SIRPα-targeting, we conducted a single-dose toxicity study in cynomolgus monkeys and did not observe obvious signs of toxicity with ADU-1805, in part illustrated by the stable hemoglobin levels in blood, and the lack of acute anemia and thrombocytopenia.